Literature DB >> 931365

Antibiotic susceptibility of Chlamydia trachomatis.

H J Blackman, C Yoneda, C R Dawson, J Schachter.   

Abstract

The antibiotic susceptibility of Chlamydia trachomatis isolates was determined in a tissue culture system. Representatives of all currently recognized serotypes of trachoma-inclusion conjunctivitis agents were tested. Tetracycline and erythromycin yielded similar results, with 1.0 mug/ml preventing chlamydial replication. Rifampin was the most active antibiotic, with 0.25 mug/ml completely suppressing inclusion formation of all strains. Fifty percent end points were usually achieved at one-fourth to one-eighth the 100% suppression level. Penicillin was not as effective, and the assays were often irregular. Antibiotic susceptibility of these chlamydiae was essentially the same, regardless of serotype, anatomic site infected, geographic origin, or antibiotic use in the community.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 931365      PMCID: PMC430002          DOI: 10.1128/AAC.12.6.673

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

2.  Emergence of rifampin-resistance in Chlamydia trachomatis.

Authors:  H Keshishyan; L Hanna; E Jawetz
Journal:  Nature       Date:  1973-07-20       Impact factor: 49.962

Review 3.  Chemotherapy of chlamydial infections.

Authors:  E Jawetz
Journal:  Adv Pharmacol       Date:  1969

4.  Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia.

Authors:  C R Dawson; I Hoshiwara; T Daghfous; M Messadi; D W Vastine; J Schachter
Journal:  Am J Ophthalmol       Date:  1975-05       Impact factor: 5.258

5.  Susceptibility of Chlamydia to antibacterial drugs: test in cell cultures.

Authors:  F B Gordon; A L Quan
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  5 in total
  15 in total

1.  Acute and chronic urinary tract infections caused by Chlamydia trachomatis.

Authors:  M Wanic-Kossowska; L Kozioł; L Bajew; S Czekalski
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.

Authors:  L E Welsh; C A Gaydos; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

3.  Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.

Authors:  Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

4.  In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.

Authors:  M Walsh; E W Kappus; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 5.  Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies.

Authors:  J M Ehret; F N Judson
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 6.  Spectrum of human chlamydial infections.

Authors: 
Journal:  West J Med       Date:  1981-09

7.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

8.  Relative resistance to erythromycin in Chlamydia trachomatis.

Authors:  A Mourad; R L Sweet; N Sugg; J Schachter
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

9.  Epidemiology and therapy of Chlamydia trachomatis infections.

Authors:  W R Bowie
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

10.  In vitro and in vivo efficacy of antimicrobials against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Infection       Date:  1982       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.